Dose-Response Relationship between Alanine Aminotransferase Levels within the Reference Interval and Metabolic Syndrome in Chinese Adults

키워드

참고문헌 (35)

1. Alberti KG, "Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute;American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity", Circulation, 120, pp.1640~1645 (2009)
2. Mottillo S, "The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis", J Am Coll Cardiol, 56, pp.1113~1132 (2010)
3. Khang YH, "Risks for cardiovascular disease, stroke, ischaemic heart disease, and diabetes mellitus associated with the metabolic syndrome using the new harmonised definition: findings from nationally representative longitudinal data from an Asian population", Atherosclerosis, 213, pp.579~585 (2010)
4. Mozumdar A, "Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006", Diabetes Care, 34, pp.216~219 (2011)
5. Xi B, "Prevalence of metabolic syndrome and its influencing factors among the Chinese adults: the China Health and Nutrition Survey in 2009", Prev Med, 57, pp.867~871 (2013)
6. Owen N, "Too much sitting:the population health science of sedentary behavio", Exerc Sport Sci Rev, 38, pp.105~113 (2010)
7. James PT, "Obesity: the worldwide epidemic", Clin Dermatol, 22, pp.276~280 (2004)
8. Schindhelm RK, "Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease", Diabetes Metab Res Rev, 22, pp.437~443 (2006)
9. Goessling W, "Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease", Gastroenterology, 135, pp.1935~1944 (2008)
10. Janicˇko M, "Redefining the alanine aminotransferase upper limit of normal improves the prediction of metabolic syndrome risk", Eur J Gastroenterol Hepatol, 27, pp.405~411 (2015)
11. 김현창, "Normal Serum Aminotransferase Levels and the Metabolic Syndrome: Korean National Health and Nutrition Examination Surveys", Yonsei Medical Journal, 47(4), pp.542~550 (2006), 연세대학교의과대학
12. Suh SY, "The association between normal alanine aminotransferase levels and the metabolic syndrome: 2005 Korean National Health and Nutrition Examination Survey", Metabolism, 58, pp.1731~1736 (2009)
13. Steinvil A, "The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome", Cardiovasc Diabetol, 9, pp.30~ (2010)
14. Bethel MA, "Metabolic syndrome and alanine aminotransferase:a global perspective from the NAVIGATOR screening population", Diabet Med, 26, pp.1204~1211 (2009)
15. Liu Z, "Elevated alanine aminotransferase is strongly associated with incident metabolic syndrome: a meta-analysis of prospective studies", PLoS One, 8, pp.e80596~ (2013)
16. WHO, "Guidelines for controlling and monitoring the tobacco epidemic", World Health Organization, ~ (1998)
17. Ma G, "The drinking practice of people in China", Acta Nutrimenta Sinica, 27, pp.362~365 (2005)
18. Wang X, "Prevalence of the metabolic syndrome among employees in Northeast China", Chin Med J, 128, pp.1989~1993 (2015)
19. Desquilbet L, "Dose-response analyses using restricted cubic spline functions in public health research", Stat Med, 29, pp.1037~1057 (2010)
20. Polotsky HN, "Metabolic implications of menopause", Semin Reprod Med, 28, pp.426~434 (2010)
21. Murphy MJ, "Girls at five are intrinsically more insulin resistant than boys:The Programming Hypotheses Revisited--The EarlyBird Study (EarlyBird 6)", Pediatrics, 113(1 Pt 1), pp.82~86 (2004)
22. Ehm MG, "Genomewide search for type 2 diabetes susceptibility genes in four American populations", Am J Hum Genet, 66, pp.1871~1881 (2000)
23. Clark JM, "The prevalence and etiology of elevated aminotransferase levels in the United States", Am J Gastroenterol, 98, pp.960~967 (2003)
24. Tarantino G, "What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?", World J Gastroenterol, 19, pp.3375~3384 (2013)
25. Gariani K, "Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside", Diabetes Metab, 39, pp.16~26 (2013)
26. Sookoian S, "Alanine and aspartate aminotransferase and glutamine-cycling pathway: their roles in pathogenesis of metabolic syndrome", World J Gastroenterol, 18, pp.3775~3781 (2012)
27. Hanley AJ, "Alanine aminotransferase and directly measured insulin sensitivity in a multiethnic cohort: the Insulin Resistance Atherosclerosis Study", Diabetes Care, 30, pp.1819~1827 (2007)
28. Yamada J, "Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome", Atherosclerosis, 189, pp.198~205 (2006)
29. 김규남, "Irritable Bowel Syndrome May Be Associated with Elevated Alanine Aminotransferase and Metabolic Syndrome", Yonsei Medical Journal, 57(1), pp.146~152 (2016), 연세대학교의과대학[DOI]
30. Harrison SA, "HCV therapy in 2006: down with ALT levels, in with awareness of co-existent metabolic syndrome", J Hepatol, 44, pp.624~626 (2006)
31. Wu WC, "Updated thresholds for serum alanine aminotransferase level in a largescale population study composed of 34 346 subjects", Aliment Pharmacol Ther, 36, pp.560~568 (2012)
32. Prati D, "Updated definitions of healthy ranges for serum alanine aminotransferase levels", Ann Intern Med, 137, pp.1~10 (2002)
33. Kunde SS, "Spectrum of NAFLD and diagnostic implications of the proposed new normal range for serum ALT in obese women", Hepatology, 42, pp.650~656 (2005)
34. Wei D, "Association of serum gamma-glutamyl transferase and ferritin with the metabolic syndrome", J Diabetes Res, 2015, pp.741731~ (2015)
35. Lu YH, "Comparison of the diagnostic criteria of metabolic syndrome by International Diabetes Federation and that by Chinese Medical Association Diabetes Branch", Zhonghua Yi Xue Za Zhi, 86, pp.386~389 (2006)

관련 논문AI추천